Global Acne Treatment Market Size to Reach USD 13.59 Billion in 2030 | Emergen Research

Increase in launch of novel acne products and rising demand for personal wellness and smooth spotless skin due to high psychological burden associated with acne are driving global acne treatment market revenue growth

Vancouver, Sept. 20, 2023 (GLOBE NEWSWIRE) — The global acne treatment market size was USD 9.10 Billion in 2021 and is expected to register a revenue CAGR of 4.6% over the forecast period, according to the latest analysis by Emergen Research. Increase in launch of novel acne products and rising demand for personal wellness and smooth spotless skin due to high psychological burden associated with acne are some key factors driving acne treatment market revenue growth. In addition, growing consumption of unhealthy food is increasing acne problems, which is further increasing the demand for acne treatment.

Rising demand for personal wellness and smooth spotless skin due to high psychological burden associated with acne has led to an increasing number of launches of novel acne products. For instance, on 28 October 2019, the United States Food and Drug Administration (USFDA) approved Amzeeq, which is a topical form of antibiotic minocycline. The drug was earlier available as an oral antibiotic, however, now it is available in non-pill form and delivers minocycline in form of foam. Foamix Pharmaceuticals, a manufacturer of the product has leveraged its proprietary Molecule Stabilizing Technology (MST) platform to deliver minocycline effectively in a foam-based vehicle. The production of such innovative and novel products for treatment of acne is expected to substantially propel market revenue growth.

Get Free Exclusive Sample PDF Copy @ https://www.emergenresearch.com/request-sample/1135

Additionally, growing consumption of unhealthy food is increasing acne problems is another factor that can increase prevalence of acne among people of all ages, which can significantly increase demand for acne treatment products. Consumption of food products with high sugar in products, such as pastries, cakes, and soda cans, significantly worsens acne. According to a research report conducted on 2,258 patients who were placed on a low-glycemic diet, it was noted that 87% of patients reported reduced acne. However, increasing number of fast-food outlets and popularity of street food is expected to contribute to growing prevalence of acne and hence driving growth of the market.

Factors, such as skin positivity movement and lack of awareness about skin issues, are restraining revenue growth of the market. Poor understanding of risk factors for skin infections, such as acne may delay recognition of symptoms of some harmful skin ailments and further delay treatment. However, an increase in awareness campaigns by various skincare professionals through social media and launch of novel products to cure acne is expected to support growth of the market in long term.

Click to Purchase this Report at an Exclusively Discounted Rate @ https://www.emergenresearch.com/request-discount/1135

Scope of Research

Report Details	Outcome
Market Size in 2021	USD 9.10 Billion
CAGR (2022–2030)	4.6%
Size Forecast to 2030	USD 13.59 Billion
Base Year for Estimation	2021
Historical Data	2019–2020
Forecast Period	2022–2030
Quantitative Units	Revenue in USD Billion, and CAGR in % from 2022 to 2030
Report Coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered	Product, administration, end user, and region
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country Scope	U.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, Israel, and Rest of Middle East & Africa
Key Companies Profiled	Botanix Pharmaceuticals, Galderma S.A., Ortho Dermatologics (Bausch Health Companies Inc.), GSK plc, Bayer AG, Johnson & Johnson Services, Inc., Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., and Almirall, S.A
Customization Scope	10 hours of free customization and expert consultation.

Major Companies and Competitive Landscape

The global acne treatment market is consolidated with a few large and medium-sized players accounting for majority of market revenue. Established companies are engaged in various research & development activities and initiatives to develop and deploy new and more efficient technologies in the acne treatment market. Some major companies included in the global market report are:

• Botanix Pharmaceuticals
• Galderma S.A.
• Ortho Dermatologics (Bausch Health Companies Inc.)
• GSK plc
• Bayer AG
• Johnson & Johnson Services, Inc.
• Pfizer Inc.
• AbbVie Inc.
• Teva Pharmaceutical Industries Ltd.
• Almirall, S.A

Strategic Development

• On 5 January 2022,     Galderma S.A. completed its acquisition of ALASTIN Skincare, Inc. after receiving an antitrust clearance from federal authorities of the U.S. Increasing consumer interest and growing popularity of aesthetic skin care procedures had led to a rise in demand for effective products and robust portfolio of ALASTIN and experience in scientific skincare products will increase ability of Galderma to serve a wide range of customers.
• On 19 December 2019, Ortho Dermatologics (Bausch Health Companies Inc.), a U.S.-based largest prescription dermatology health care business received approval from the U.S. Food and Drug Administration (FDA) for its new drug application for ARAZLO Lotion, 0.045%, for topical treatment of acne vulgaris for patients 9 years and older. It is the first tazarotene acne treatment available in a form of lotion and has proved to be highly effective for treating acne

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1135

Some Key Highlights from the Report

• On 24 February 2020, Almirall, S.A, announced to send its product Seysara (sarecycline) to the Chinese regulatory body NMPA in 2023 for approval. It is an innovative tetracycline-derived oral antibiotic used for treatment of inflammatory lesions of moderate to severe acne vulgaris. Almirall S.A has commercialization rights for this product in the U.S., and under a License Agreement from Paratek Pharmaceuticals, Inc., it will develop, register, and commercialize the product in China in exchange for royalties.
• The antibiotics segment revenue is expected to account for largest revenue share over the forecast period owing to its increasing popularity among people suffering from acne due to its effectiveness. In addition, increasing launch of new antibiotics are more effective due to an increase in antibiotic resistance among patients.
• The topical segment accounted for a larger revenue share in 2021 owing to growing popularity of Over-the-Counter (OTC) drugs and rapid development of new topical therapy for treatment of acne. Additionally, an increasing number of new discoveries of topical therapy for acne patients will further contribute to revenue growth of the segment.
• The skincare clinics segment is expected to register a rapid growth rate over the forecast period. High psychological burden associated with acne and increasing demand for hormonal therapy for acne treatment is expected to sustain revenue growth of the market over the forecast period.

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends @ https://www.emergenresearch.com/industry-report/acne-treatment-market

Emergen Research has segmented the global acne treatment market based on product, administration, end user, and region:

• Product Outlook (Revenue, USD Billion, 2019–2030)
  • Retinoids
  • Antibiotics
  • Isotretinoin
  • Others
• Administration Outlook (Revenue, USD Billion, 2019–2030)
  • Oral
  • Topical
  • Injectable
• End User Outlook (Revenue, USD Billion, 2019–2030)
  • Hospitals
  • Skincare Clinics

• Regional Outlook (Revenue, USD Billion, 2019–2030)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. Spain
    5. BENELUX
    6. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. Israel
    4. Rest of Middle East & Africa

Curated Reports You Shouldn’t Miss: Dive In Now!

Cell-Free DNA (cfDNA) Testing Market By Type (Cell-free fetal DNA (NIPT), Circulating tumor DNA, Donor-derived cell-free DNA), By Technology (MPSS, t-MPS, SNP, Others), Application (Transplantation, Gynecology, Oncology), By Region Forecasts to 2027

Peritoneal Dialysis Market By Product (Peritoneal Dialysis Solution, Peritoneal Dialysis Set, Device, Catheter), By Type (CAPD, APD), By End-User (Home-Based Dialysis, Dialysis Center & Hospital Based Dialysis) and Regions Forecasts to 2027

Breath Analyzer Market, By Technology (Fuel Cells, Semiconductor Oxide Sensors, and Other Technologies), By Application (Alcohol Detection, Drug Abuse Detection, and Medical Applications), By End-Use, and By Region Forecast to 2032

Assisted Reproductive Technology (ART) Market Size, Share, Trends, By Procedure, By Technology, By End-use, and By Region Forecast to 2028

Rehabilitation Robotics Market By Type (Therapeutic, Exoskeleton, Assistive, Others), By Body Part (Lower Extremity, Upper extremity), By Therapy (Balance, Gait, Limb Mobility), By Application (Neurology, Orthopedics, Others), By Region Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Explore Our Japanese Version: Acne Treatment Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-acne-treatment-market

acquisition
otc
tsx-bhc
bausch-health-companies-inc
bausch health companies inc
press-release